Pirfedone Tablet 534 mg contains Pirfenidone, a potent antifibrotic and anti-inflammatory medication specifically indicated for the treatment of idiopathic pulmonary fibrosis (IPF). IPF is a progressive lung disease marked by excessive scarring of lung tissue, which results in reduced oxygen exchange, chronic breathlessness, fatigue, and decreased overall quality of life.
Pirfenidone works by modulating pathways that drive fibrosis and inflammation in the lungs. It inhibits the activity of transforming growth factor-beta (TGF-β) and other fibrotic mediators, reducing collagen deposition and fibroblast proliferation. Additionally, Pirfenidone suppresses inflammatory cytokines such as TNF-alpha and interleukin-1, which play a key role in tissue damage. By targeting both fibrotic and inflammatory processes, Pirfedone helps slow disease progression, preserve lung function, and improve patient outcomes.
The 534 mg tablet offers a higher-dose formulation for adults, facilitating effective titration to achieve the recommended daily dose while maintaining convenience for oral administration. Regular dosing is critical for sustaining therapeutic levels and ensuring maximal antifibrotic effect.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Contains Pirfenidone 534 mg per tablet
Antifibrotic and anti-inflammatory action for idiopathic pulmonary fibrosis
Slows lung scarring and preserves lung function
Oral tablet for convenient long-term therapy
Helps improve exercise tolerance and quality of life
Suitable for titrated dosing in adult patients under specialist supervision
Pirfedone Tablet 534 mg is indicated for:
Idiopathic Pulmonary Fibrosis (IPF): To slow disease progression and preserve lung function
Fibrosis-related respiratory conditions: Prescribed under specialist guidance
Supportive therapy: Maintains patient quality of life, exercise tolerance, and lung capacity
It should always be used under the care of a pulmonologist or specialist physician, with monitoring of lung function and general health.
Pirfenidone exerts its effect through a dual antifibrotic and anti-inflammatory mechanism:
Inhibits TGF-β and collagen synthesis, reducing fibroblast activity and excessive scarring
Suppresses inflammatory cytokines such as TNF-alpha and IL-1, preventing further tissue damage
Slows the progression of pulmonary fibrosis, helping preserve lung elasticity and respiratory function
Reduces fibroblast proliferation and extracellular matrix deposition, targeting the root cause of disease
This combined action addresses both the fibrotic and inflammatory components of IPF.
Pirfedone is usually titrated gradually to reach the recommended therapeutic dose
Tablets are taken orally three times daily with food to minimize gastrointestinal discomfort
Dose adjustments may be required in patients with liver or kidney impairment
Regular monitoring of liver function, kidney function, and lung status is essential
Adherence to prescribed dosing is crucial for effectiveness
Common side effects:
Nausea, vomiting, or diarrhea
Fatigue and dizziness
Loss of appetite
Skin rash or photosensitivity
Mild gastrointestinal discomfort
Serious but rare side effects:
Liver function abnormalities
Severe skin reactions or photosensitivity
Allergic reactions
Persistent gastrointestinal issues requiring medical attention
Patients should report any severe or unusual symptoms immediately to their physician.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Use only under specialist supervision
Avoid excessive sunlight exposure; use protective measures to prevent photosensitivity
Regular liver and kidney function monitoring is recommended
Inform your doctor about all concurrent medications to prevent drug interactions
Not recommended during pregnancy or breastfeeding without medical supervision
Store in a cool, dry place below 25°C
Protect from light and moisture
Keep tablets in the original container, tightly closed
Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet